First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosis.

Genome deciphering revealed that Mycobacterium tuberculosis encodes a single type II topoisomerase contrary to common bacteria harboring two type II topoisomerases (DNA gyrase and topoisomerase IV). Functions of the M. tuberculosis type II topoisomerase were explored after cloning and expressing the subunits encoding genes in Escherichia coli. M. tuberculosis type II topoisomerase supercoiled relaxed pBR322 with a specific activity close to that of DNA gyrases of common bacteria whereas it exhibited DNA relaxation and formation of cleavable complexes with activities significantly higher than other DNA gyrases. Intermolecular passage activity evaluated by the decatenation of kinetoplast DNA was 25-fold lower than that of the topoisomerase IV from Streptococcus pneumoniae, but was markedly higher than that of the E. coli gyrase. Overall, the type II topoisomerase of M. tuberculosis exhibits classical polyvalent activities of DNA gyrase for supercoiling but enhanced relaxation, cleavage, and decatenation activities.

[1]  N. Grishin,et al.  C‐terminal domain of gyrase A is predicted to have a β‐propeller structure , 2002 .

[2]  J. Champoux.  DNA topoisomerases: structure, function, and mechanism. , 2001, Annual review of biochemistry.

[3]  V. Nagaraja,et al.  Functional characterisation of mycobacterial DNA gyrase: an efficient decatenase. , 2002, Nucleic acids research.

[4]  V. Jarlier,et al.  Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis , 1996, Antimicrobial agents and chemotherapy.

[5]  H. Niki,et al.  New topoisomerase essential for chromosome segregation in E. coli , 1990, Cell.

[6]  L. Fisher,et al.  Streptococcus pneumoniae DNA Gyrase and Topoisomerase IV: Overexpression, Purification, and Differential Inhibition by Fluoroquinolones , 1999, Antimicrobial Agents and Chemotherapy.

[7]  W. M. Huang,et al.  Bacterial diversity based on type II DNA topoisomerase genes. , 1996, Annual review of genetics.

[8]  V. Nagaraja,et al.  Mycobacterium smegmatis DNA gyrase: cloning and overexpression in Escherichia coli. , 1995, Microbiology.

[9]  Anthony Maxwell,et al.  Small-angle X-ray scattering reveals the solution structure of the full-length DNA gyrase a subunit. , 2005, Structure.

[10]  J. Crouzet,et al.  Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases , 1996, Antimicrobial agents and chemotherapy.

[11]  H. Hiasa,et al.  DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities. , 1998, Biochimica et biophysica acta.

[12]  V. Lamour,et al.  An Open Conformation of the Thermus thermophilusGyrase B ATP-binding Domain* , 2002, The Journal of Biological Chemistry.

[13]  K. Marians,et al.  Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions. , 1993, The Journal of biological chemistry.

[14]  G. Capranico,et al.  Novel Symmetric and Asymmetric DNA Scission Determinants for Streptococcus pneumoniae Topoisomerase IV and Gyrase Are Clustered at the DNA Breakage Site* , 2005, Journal of Biological Chemistry.

[15]  V. Jarlier,et al.  Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum. , 1999, Microbiology.

[16]  P. T. Englund,et al.  Decatenation of kinetoplast DNA by topoisomerases. , 1980, The Journal of biological chemistry.

[17]  J. Berger,et al.  Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases. , 2004, Annual review of biophysics and biomolecular structure.

[18]  V. Jarlier,et al.  Mycobacterium tuberculosis DNA Gyrase: Interaction with Quinolones and Correlation with Antimycobacterial Drug Activity , 2004, Antimicrobial Agents and Chemotherapy.

[19]  J. Heddle,et al.  Nucleotide binding to DNA gyrase causes loss of DNA wrap. , 2004, Journal of molecular biology.

[20]  J. Roca.  Varying levels of positive and negative supercoiling differently affect the efficiency with which topoisomerase II catenates and decatenates DNA. , 2001, Journal of molecular biology.

[21]  C. Lerner,et al.  DNA Cleavage Activities of Staphylococcus aureus Gyrase and Topoisomerase IV Stimulated by Quinolones and 2-Pyridones , 1999, Antimicrobial Agents and Chemotherapy.

[22]  V. Nagaraja,et al.  An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity , 2005, Molecular microbiology.

[23]  James M. Berger,et al.  The C-terminal domain of DNA gyrase A adopts a DNA-bending β-pinwheel fold , 2004 .

[24]  A. Maxwell,et al.  Conversion of DNA gyrase into a conventional type II topoisomerase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  I. Morrissey,et al.  Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition , 1994, Antimicrobial Agents and Chemotherapy.

[26]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[27]  J. Berger,et al.  The structural basis for substrate specificity in DNA topoisomerase IV. , 2005, Journal of molecular biology.